Blogs
New Type Of Diabetes Pill “Likely Dead,” Says Goldman Sachs - Matthew Herper - The Medicine Show -
Goldman Sachs pharmaceuticals analyst Jami Rubin said in a note to investors that the rejection of dapagliflozin, a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, by a panel of advisers to the Food and Drug Administration probably means that safety and efficacy concerns will either
Bristol-Myers' Pipeline Advances With Type II Diabetes Drug Boost -- Seeking Alpha
<strong><a href="http://register.zacks.com/ucd/step1.php?ALERT=alpha&ADID=ALPHA_content_welcome">Zacks.com</a>submits:</strong><p><strong>Bristol-Myers Squibb Company’s (<a href='http://seekingalpha.com/symbol/bmy' title='Bristol-Myers Squibb Co.'>BMY</a>)</strong>pipeline received a boost
BIDMC data marts | Healthcare IT News
<p>At BIDMC, our clinical systems are written in a hierarchical database called Cache - a very fast transactional system with great reliability and disaster recovery features.</p><p>However, for population health, quality, and performance analysis, we export our clinical care data into over 80 data
Diabetes expected to double, costs to triple by 2034 - Wellness - TIME.com
According to estimates from researchers at the University of Chicago, the total number of Americans with diabetes will double in the next 25 years, from the current 23.7 million to some 44.1 million in 2034.
Januvia Linked to Pancreatitis by FDA - Health Blog - WSJ
An FDA notice on Merck's Januvia comes just over a year after Byetta was also linked to pancreatitis.
Look at the states we're in
Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search [BLOG HOMEPAGE] Look at the states we're in By Michael Woodhead,
Crumlin gets new diabetes facilities — Irish Medical Times
February 4, 2012 Home Contact Us About Us Subscribe Advertising Terms of Use Privacy Policy Sitemap RSS Feeds Irish Medical Times News Opinion Features Editorial Letters Blogs Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads You are here: Home / Blogs / Hospital Medicine / Crumlin gets
“Other” Carbohydrates On the Label « Healthy Recipe Doctor
From low fat recipes, to recipes designed for diabetics, Elaine Magee RD, MPH shares recipes and advice to create healthy meals that are guaranteed to please.
BMY Presents Encouraging Data on Diabetes Drug -- Seeking Alpha
<strong><a href="http://register.zacks.com/ucd/step1.php?ALERT=alpha&ADID=ALPHA_content_welcome">Zacks.com</a>submits:</strong><p><font size="2">Recently,</font><strong>Bristol-Myers Squibb Company’s (<a href='http://seekingalpha.com/symbol/bmy' title='Bristol-Myers Squibb
U.K. Regulator Says GSK's Diabetes Drug Should Go -- Seeking Alpha
<strong><a href='http://www.pharmalot.com/'>Pharmalot</a>submits:</strong><p><img src="http://static.seekingalpha.com/uploads/2010/9/7/saupload_avandia_2.jpg" align="right" alt="avandia-2" hspace="6" vspace="6" width="90" height="129" />There is a flurry of activity surrounding the controversial
Refine by Content Type:
Refine by Source:
- blogs.webmd.com (89)
- seekingalpha.com (37)
- www.6minutes.com.au (3)
- www.imt.ie (2)
- blogs.forbes.com (1)
- blogs.wsj.com (1)
- wellness.blogs.time.com (1)
- www.healthcareitnews.com (1)
